HOME >> BIOLOGY >> NEWS
Halfway human

Delson recreated the shape of SM3's skull using coordinates from some 200 points on its surface. He did the same for 23 other specimens-11 H. erectus, 10 modern H. sapiens, and 2 archaic H. sapiens. With this information, his computer program arranged the specimens according to their similarity, placing SM3 just about squarely between the erectus and modern humans-while even the archaic H. sapiens fell in among the erectus specimens.

Next, Delson told the computer that there were categories called "erectus", "sapiens" and "archaic", and asked it to find features that would force known members of each group closer together. Again the program lumped archaic H. sapiens in with the erectus specimens. And when Delson asked the computer to categorise the unknown SM3 it still ended up floating between the two main groups, though a bit closer to the erectus cluster. Delson therefore feels comfortable designating SM3 as an erectus, albeit a strange one. He suggests three possible explanations for her odd looks. She could have been an aberrant individual. She could be a member of a hitherto unknown population of Indonesian H. erectus with bulging foreheads. Or, he acknowledges, she could represent "a population evolving in the direction of modern humans". The last explanation is music to the ears of multiregionalists. "That is very daring for him to say," says Wolpoff. "If you thought Homo sapiens began in Africa, as I know [Delson] does, then something in Indonesia has no business evolving in that direction."

But SM3 doesn't even have to be the long-awaited missing link to be troublesome. The finding that she fits so poorly into existing species categories seems to highlight an ongoing problem in paleoanthropology. The experts still argue over what constitutes H. erectus, an enormous group that has been called "the muddle in the middle" because it spans more than a million years and includes many specimens, from Indonesia, Asia and Africa, that don't neces
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
10-Apr-2001


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
2. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
3. Most recent common ancestor of all living humans surprisingly recent
4. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
5. Bronfenbrenner book sums up human development
6. No role for simian virus 40 in human pleural mesotheliomas
7. Sugar-coated sea urchin eggs could have sweet implications for human fertility
8. Serotonin metabolites in mollusks suggest pathways for human therapies
9. Wrapping a memory with an experience, capacity for recollection detected in non-human species
10. Viral suspect for amphibian decline traced to human spread through bait
11. Recent evolution at a single gene may have brought down heart disease risk in some human groups

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Halfway human

(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
(Date:4/16/2015)... 2015 OncoTAb, Inc., ... Charlotte) spin-out company, announced today the appointment of ... as Chief Operating Officer (COO). Cooper brings to ... developing clinical diagnostic and biotechnology platforms in the ... Cooper’s extensive career transcends the field of medical ...
(Date:4/16/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. ... the orphan disorder, neurotrophic keratopathy (NK), and a ... (DES) in the U.S.  Both trials will be ... Each of these eye disorders was being targeted ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: